Safety and efficacy of opicinumab in acute optic neuritis (RENEW): a randomised, placebo-controlled, phase 2 trial

DSpace Repository

Safety and efficacy of opicinumab in acute optic neuritis (RENEW): a randomised, placebo-controlled, phase 2 trial

Author: Cadavid, Diego; Balcer, Laura; Galetta, Steven; Aktas, Orhan; Ziemssen, Tjalf; Vanopdenbosch, Ludo; Frederiksen, Jette; Skeen, Mark; Jaffe, Glenn J.; Butzkueven, Helmut; Ziemssen, Focke; Massacesi, Luca; Chai, Yi; Xu, Lei; Freeman, Stefanie
Tübinger Autor(en):
Ziemssen, Focke
Published in: Lancet Neurology (2017), Bd. 16, H. 3, S. 189-199
Verlagsangabe: Elsevier Science Inc
Language: English
Full text: https://doi.org/10.1016/S1474-4422(16)30377-5
ISSN: 1474-4465
DDC Classifikation: 610 - Medicine and health
Dokumentart: Artikel
Show full item record

This item appears in the following Collection(s)